Senior Director, Global Commercial Development, Early Detection & Market Shaping
New
R
Revolution MedicinesOncology pharmaceuticals
Remote (United States)Full-TimeDirector
Salary232,000 - 290,000 USD per year
Apply NowOpens the employer's application page
Job Details
- Experience
- Bachelor’s degree with at least 15 years, or advanced degree with at least 8 years, of progressive commercial experience
Requirements
- Bachelor’s degree with at least 15 years, or an advanced degree with at least 8 years, of progressive commercial experience in a biotechnology and/or pharmaceutical company.
- Experience in strategic marketing; sales experience is preferred.
- Proven success developing and executing global commercial strategy and influencing cross-functional product or disease-area teams.
- Ability to derive actionable insights and analytics that inform commercial strategies and investment decisions.
- Leadership skills, including leading teams, collaborating across functions, and influencing without direct authority.
- Strong clinical and scientific acumen, including translating preclinical and clinical data into commercial implications.
- Strong written, verbal, and executive communication skills and ability to represent the company with external stakeholders.
- Ability to assess clinical, economic, and practical feasibility of screening, surveillance, and diagnostic strategies.
- Up to 50% travel required.
- Preferred: experience in pancreatic or other gastrointestinal cancers, oncology diagnostics, or developing new disease-area markets.
- Preferred: experience with screening or surveillance initiatives, molecular diagnostics, liquid biopsy, imaging, or AI-enabled diagnostic pathways.
- Preferred: experience building external alliances across industry, academic medicine, patient advocacy, and healthcare systems.
Responsibilities
- Own the global commercial market-shaping strategy for pancreatic cancer early detection, including high-risk identification, surveillance, symptom recognition, diagnostic work-up, and referral to multidisciplinary care.
- Map patient-journey barriers and opportunities from symptoms or high-risk status through diagnosis, staging, and treatment access, and develop hypotheses for improving earlier-stage care pathways.
- Assess blood-based detection tests, molecular biomarkers, AI-enabled imaging, radiology tools, and other diagnostic approaches, translating evidence maturity and workflow requirements into commercial implications.
- Map academic centers, research networks, healthcare delivery partners, technology and diagnostic companies, and patient advocacy organizations; recommend partnership opportunities.
- Lead global market research, epidemiology and patient-flow analyses, screening and adoption scenarios, stage-shift assumptions, and assessments of investment needed to enable earlier diagnosis.
- Partner with Medical Affairs, Corporate Affairs, Patient Advocacy, and review functions on compliant, unbranded disease-awareness, provider education, and patient-engagement strategies.
- Collaborate with Clinical Development, Medical Affairs, Precision Medicine/Diagnostics, Market Access, and external partners to identify evidence needs, operational dependencies, and payer or health-system considerations.
- Translate stakeholder insights into market-shaping priorities and coordinate early-detection planning with daraxonrasib and zoldonrasib commercial leaders.
- Prepare executive-level recommendations, scenario analyses, measurable milestones, and phased investment plans, aligning U.S. and key ex-U.S. perspectives.
- Select and direct agencies, research vendors, and specialist partners; partner with IS Commercial and analytics teams on digital, omnichannel, and data-driven approaches.
View Full Description & ApplyYou'll be redirected to the employer's site
